by American College of Rheumatology Micrograph of a heart with fibrosis (yellow) and amyloidosis (brown). Movat’s stain. Credit: Nephron/Wikipedia New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE). Antiphospholipid...
Tag: <span>cardiovascular disease risk</span>
Post
AI technique identifies people who would benefit most from treatment to reduce future cardiovascular disease risk
by Enrique Rivero, University of California, Los Angeles Credit: Pixabay/CC0 Public Domain New UCLA research suggests that a novel machine-learning technique known as “causal forest” was about five times more efficient than the current clinical practice of treating patients with high blood pressure. Under current practice, physicians treat patients with high blood pressure under the assumption that people at...